Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ran Wang (Hefei, China), Ran Wang, Gengyun Sun, Sijing Zhou. Cigarette smoking alters microRNA expression profiling and contributes to pulmonary artery remodeling via targeting connective tissue growth factor. Eur Respir J 2015; 46: Suppl. 59, 588

Member's Comments

No comment yet.

Related content which might interest you: Bone morphogenetic protein receptor-II as a regulator of pulmonary artery endothelial cell permeability: Relevance to the initiation and progression of heritable pulmonary arterial hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Pulmonary artery endothelial cell exposure to hepcidin affects BMP-signalling; relevance to vascular remodelling in PAH Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 RASSF1A regulates ROS-HIF axis in hypoxia driven pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: novel insights Year: 2016 Pulmonary hypertension in smoking mice over-expressing protease-activated receptor-2 Source: Eur Respir J 2011; 37: 823-834 Year: 2011 The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Tobacco smoking and pulmonary endothelial dysfunction Source: Eur Respir J 2007; 30: Suppl. 51, 607s Year: 2007 PP218 – Direct effects of cigarette smoke in pulmonary arterial cells: Implications in arterial remodeling and vascular tone maintenance Source: ERS Lung Science Conference 2021 Year: 2021 Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension Source: Eur Respir J 2009; 34: 662 Year: 2009 Cigarette smoke- and hypoxia-induced imbalanced vasoactive gene expression in human pulmonary artery smooth muscle cells Source: International Congress 2017 – Experimental PH Year: 2017 Involvement of FHL1 in vascular remodelling Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 Risk factors for pulmonary hypertension and associations with lung function in connective tissue diseases Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Smoking, systemic inflammation and pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 248s Year: 2006 Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 The transcription factor slug is increased in pulmonary artery endothelial cells of COPD patients Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Tobacco smoking factor and pulmonary pathology Source: Eur Respir J 2001; 18: Suppl. 33, 115s Year: 2001 Gene expression of angiogenic factors in pulmonary arteries from COPD Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension Year: 2009 The gene expression of the endothelial to mesenchymal transition-related transcription factor slug is increased in remodelled pulmonary arteries of COPD Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Cigarette smoke exposure induces endothelial dysfunction in pulmonary arteries in the guinea pig Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis Source: Eur Respir J 2006; 27: 957-963 Year: 2006 Effects of cigarette smoke and hypoxia on pulmonary circulation in the guinea pig Source: Eur Respir J 2011; 38: 617-627 Year: 2011